Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases.
Saruwatari K, Ikeda T, Saeki S, Shingu N, Imamura K, Komatu T, Ushijima S, Maruyama H, Kashiwabara K, Tomita Y, Ichiyasu H, Fujii K, Sakagami T. Saruwatari K, et al. Among authors: sakagami t. Anticancer Res. 2019 Feb;39(2):923-931. doi: 10.21873/anticanres.13195. Anticancer Res. 2019. PMID: 30711977
The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment.
Sakata Y, Kawamura K, Ichikado K, Shingu N, Yasuda Y, Eguchi Y, Anan K, Hisanaga J, Nitawaki T, Iio M, Sekido Y, Nakano A, Sakagami T. Sakata Y, et al. Among authors: sakagami t. Lung Cancer. 2019 Apr;130:159-161. doi: 10.1016/j.lungcan.2019.02.011. Epub 2019 Feb 14. Lung Cancer. 2019. PMID: 30885338
Small Cell Lung Cancer Derived from Adenocarcinoma with Mutant Epidermal Growth Factor Receptor Provides a Signature of Transcriptional Alteration in Tumor Cells.
Tenjin Y, Nakamura K, Ishizuka S, Saruwatari K, Sato R, Tomita Y, Saeki S, Ichiyasu H, Fujii K, Ito T, Sakagami T. Tenjin Y, et al. Among authors: sakagami t. Intern Med. 2019 Nov 15;58(22):3261-3265. doi: 10.2169/internalmedicine.2988-19. Epub 2019 Jul 10. Intern Med. 2019. PMID: 31292388 Free PMC article.
Comparisons between tumor burden and other prognostic factors that influence survival of patients with non-small cell lung cancer treated with immune checkpoint inhibitors.
Sakata Y, Kawamura K, Ichikado K, Shingu N, Yasuda Y, Eguchi Y, Hisanaga J, Nitawaki T, Iio M, Sekido Y, Nakano A, Sakagami T. Sakata Y, et al. Among authors: sakagami t. Thorac Cancer. 2019 Dec;10(12):2259-2266. doi: 10.1111/1759-7714.13214. Epub 2019 Nov 3. Thorac Cancer. 2019. PMID: 31679185 Free PMC article.
Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy.
Akaike K, Saruwatari K, Oda S, Shiraishi S, Takahashi H, Hamada S, Iyama S, Horio Y, Tomita Y, Saeki S, Okamoto S, Ichiyasu H, Fujii K, Sakagami T. Akaike K, et al. Among authors: sakagami t. Int J Clin Oncol. 2020 Apr;25(4):681-690. doi: 10.1007/s10147-019-01584-x. Epub 2019 Nov 28. Int J Clin Oncol. 2020. PMID: 31781994
320 results